[1]冯春念,曾琳智,王仕均,等. 2型糖尿病与糖尿病肾病患者微炎症及肠道微生物多样性分析[J].中国微生态学杂志,2020,32(11):1273-1278. DOI:10.13381/j.cnki.cjm.202011006.
FENG C N,ZENG L Z,WANG S J,et al. Analysis of microinflammation and intestinal microbial diversity in patients with type 2 diabetes mellitus and diabetes kidney disease[J].Chinese Journal of Microecology,2020,32(11):1273-1278. DOI:10.13381/j.cnki.cjm.202011006.
[2]GUO J,GAO Y B,WANG Y X,et al. Application of herbal medicines with heat-clearing property to anti-microinflammation in the treatment of diabetic kidney disease[J].Evid - Based Complementary Altern Med,2019,2019:6174350. DOI:10.1155/2019/6174350.
[3]朱志伟,叶玉燕,陈丽萍,等. 糖尿病肾病患者自身免疫及微炎症指标间的相关性和肾功能关系的研究[J].中国预防医学杂志,2020,21(6):628-631. DOI:10.16506/j.1009-6639.2020.06.007.
ZHU Z W,YE Y Y,CHEN L P,et al. Association between autoimmune and microinflammatory markers and renal function in patients with diabetic nephropathy[J].China Preventive Medicine,2020,21(6):628-631. DOI:10.16506/j.1009-6639.2020.06.007.
[4]常冬元,陈旻,赵明辉.糖尿病肾病:审时度势,迎接新的挑战[J].中华内科杂志,2020,59(11):833-835. DOI:10.3760/cma.j.cn112138-20200820-00769.
CHANG D Y,CHEN M,ZHAO M H.Diabetic kidney disease:current situation and future challenges[J].Chinese Journal of Internal Medicine,2020,59(11):833-835. DOI:10.3760/cma.j.cn112138-20200820-00769.
[5]HEINZELMANN M,MERCER-JONES M A,FLODGAARD H,et al. Heparin-binding protein (CAP37) is internalized in monocytes and increases LPS-induced monocyte activation[J].J Immunol,1998,160(11):5530-5536.
[6]李晓慧,岳胜,杜小静,等. ICU重症感染患者血清C-反应蛋白、内毒素、肝素结合蛋白水平及其预测价值[J].中华医院感染学杂志,2020,30(17):2647-2651. DOI:10.11816/cn.ni.2020-192773.
LI X H,YUE S,DU X J,et al. Value of serum C-reactive protein,endotoxin,heparin binding protein in prediction of prognosis of ICU patients with severe infection[J].Chinese Journal of Nosocomiology,2020,30(17):2647-2651. DOI:10.11816/cn.ni.2020-192773.
[7]YANG Y,LIU G,HE Q,et al. A promising candidate:heparin-binding protein steps onto the stage of sepsis prediction[J].J Immunol Res,2019,2019:7515346. DOI:10.1155/2019/7515346.
[8]苗玲,赵勇.肝素结合蛋白与溶菌酶及不同炎性细胞因子对肺移植患者肺部感染的诊断价值[J].中华医院感染学杂志,2020,30(12):1865-1869. DOI:10.11816/cn.ni.2020-192339.
MIAO L,ZHAO Y.Diagnostic value of heparin-binding protein,lysozyme and different inflammatory cytokines on pulmonary infection in patients with lung transplantation[J].Chinese Journal of Nosocomiology,2020,30(12):1865-1869. DOI:10.11816/cn.ni.2020-192339.
[9]BONCLER M,WU Y,WATALA C.The multiple faces of C-reactive protein-physiological and pathophysiological implications in cardiovascular disease[J].Molecules,2019,24(11):2062.
[10]SACK G H Jr.Serum amyloid A (SAA) proteins[J].Subcell Biochem,2020,94:421-436.
[11]余希,莫金英,周金坊,等. 三种感染性疾病降钙素原水平比较[J].中华医院感染学杂志,2021,31(4):535-538. DOI:10.11816/cn.ni.2021-200996.
YU X,MO J Y,ZHOU J F,et al. Procalcitonin analysis of three infectious diseases[J].Chinese Journal of Nosocomiology,2021,31(4):535-538. DOI:10.11816/cn.ni.2021-200996.
[12]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344. DOI:10.19538/j.nk2018040108.
Chinese Diabetes Society.Guidelines for the prevention and control of type 2 diabetes in China (2017 edition)[J].Chinese Journal of Practical Internal Medicine,2018,38(4):292-344. DOI:10.19538/j.nk2018040108.
[13]中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识(2014年版)[J].中华糖尿病杂志,2014,6(11):792-801. DOI:10.3760/cma.j.issn.1674-5809.2014.11.004.
[14]李飞,邓庆梅,黄山,等. 肾小球滤过率评估方程在糖尿病患者中的应用[J].中国医学影像技术,2017,33(8):1246-1251. DOI:10.13929/j.1003-3289.201703111.
LI F,DENG Q M,HUANG S,et al. Application of estimation equations for glomerular filtration rate intype 2 diabetes mellitus[J].Chinese Journal of Medical Imaging Technology,2017,33(8):1246-1251. DOI:10.13929/j.1003-3289.201703111.
[15]FISHER J,LINDER A,BENTZER P,et al. Is heparin-binding protein inhibition a mechanism of albumin's efficacy in human septic shock?[J].Crit Care Med,2018,46(5):e364-374. DOI:10.1097/CCM.0000000000002996.
[16]范福玲,董艳彩,王君华,等. 老年慢性肾衰竭透析后感染患者的HBP和NLR水平[J].中华医院感染学杂志,2020,30(12):1840-1844. DOI:10.11816/cn.ni.2020-192682.
FAN F L,DONG Y C,WANG J H,et al. HBP and NLR of elderly chronic renal failure patients with infection after nemodialysis[J].Chinese Journal of Nosocomiology,2020,30(12):1840-1844. DOI:10.11816/cn.ni.2020-192682.
[17]周先锋,阮晓楠,于思雨,等. 血清C反应蛋白与糖尿病发病风险的关系[J].中华糖尿病杂志,2017,9(2):106-111. DOI:10.3760/cma.j.issn.1674-5809.2017.02.006.
ZHOU X F,RUAN X N,YU S Y,et al. Association between C-reactive protein and the risk of diabetes[J].Chinese Journal of Diabetes Mellitus,2017,9(2):106-111. DOI:10.3760/cma.j.issn.1674-5809.2017.02.006.
[18]黄力.免疫炎症与糖尿病肾病[J].肾脏病与透析肾移植杂志,2019,28(3):247-251. DOI:10.3969/j.issn.1006-298X.2019.03.011.
HUANG L.Immunity and inflammation in diabetic nephropathy[J].Chinese Journal of Nephrology,Dialysis & Transplantation,2019,28(3):247-251. DOI:10.3969/j.issn.1006-298X.2019.03.011.
[19]SAULNIER P J,DIETER B P,TANAMAS S K,et al. Association of serum amyloid A with kidney outcomes and all-cause mortality in American indians with type 2 diabetes[J].Am J Nephrol,2017,46(4):276-284. DOI:10.1159/000481269.
[20]慕婉晴,顾国嵘.降钙素原(PCT)在脓毒症临床诊断治疗中作用的研究进展[J].复旦学报(医学版),2019,46(1):103-107. DOI:10.3969/j.issn.1672-8467.2019.01.018.
MU W Q,GU G R.The clinical research progress of procalcitonin (PCT) in the diagnosis and treatment of sepsis[J].Fudan University Journal of Medical Sciences,2019,46(1):103-107. DOI:10.3969/j.issn.1672-8467.2019.01.018.